Synexa Insights
The Latest Insights From Our Scientists
Identifying biomarkers of success: Integrated bioanalysis for glioblastoma CAR-T cell clinical trials
Glioblastoma remains one of the most aggressive and treatment-resistant cancers. Standard therapies often fail, leaving patients with limited options.…
Allogeneic CAR T cell therapies: A major step forward
In a groundbreaking clinical trial, three individuals suffering from severe autoimmune diseases have entered remission following a novel CAR T…
A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology
Are antibody-drug conjugates (ADCs), principally comprised of an antibody, a cytotoxic payload and a linker, the next therapeutic modality of…
The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers
Following Covid-19, the world is collectively on high alert for anything that could indicate another pandemic. What do we know…
The STING in the tail: How our own defense mechanisms to infection may be working against us
In this latest blog, we explore this pathway, its burgeoning links to multiple diseases and how biomarker profiling can assist…
Falling drug approval rates: What should we be doing differently?
Over the years, this failure rate of drug approvals has not seen significant improvement, which begs the question - why?…
Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer
We highlight some of the exciting translational tools that have been developed to understand brain cancer and how these are…
Primary Immunodeficiency Week: The promise of gene therapy
In this blog, we delve deeper into the exciting world of gene therapy for PIDs.…
From Pottiphar to Potts: Skeletal TB from Ancient Egypt to the Present Day
Exploring the origins of TB in Ancient Egypt to present day biomarkers used to identify and treat the disease.…
Bridging the Gap: Translating Animal Model Findings to Clinical Oncology Breakthroughs
This blog delves into the historical significance, current challenges, and promising innovations shaping translational science research.…
Improving the quality of human health
Contact us
Discuss biomarker and bioanalytical solutions to accelerate your therapeutic pipeline
